Expression Genomics of cervical cancer: Molecular classification and prediction of radiotherapy response by DNA microarray
Publication in refereed journal


Full Text

Times Cited
Web of Science80WOS source URL (as at 26/10/2020) Click here for the latest count

Other information
AbstractPurpose: The incidence and mortality rates of cervical cancer are declining in the United States; however, worldwide, cervical cancer is still one of the leading causes of death in women, second only to breast cancer. This disparity is at least partially explained by the absence of or comparatively ineffective screening programs in the developing world. Recent advances in expression genomics have enabled the use of DNA microarray to profile gene expression of various cancers. These expression profiles may be suitable for molecular classification and prediction of disease outcome and treatment response. We envision that expression genomics applied in cervical cancer may provide a more rational approach to the classification and treatment of the disease.
All Author(s) ListWong YF, Selvanayagam ZE, Wei N, Porter J, Vittal R, Hu R, Lin Y, Liao J, Shih JW, Cheung TH, Lo KWK, Yim SF, Yip SK, Ngong DT, Siu N, Chan LKY, Chan CS, Kong T, Kutlina E, McKinnon RD, Denhardt DT, Chin KV, Chung TKH
Journal nameClinical Cancer Research
Year2003
Month11
Day15
Volume Number9
Issue Number15
PublisherAMER ASSOC CANCER RESEARCH
Pages5486 - 5492
ISSN1078-0432
eISSN1557-3265
LanguagesEnglish-United Kingdom
Web of Science Subject CategoriesOncology; ONCOLOGY

Last updated on 2020-27-10 at 01:42